Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Ebiomedicine|May 12, 2018
Predominant Asymmetrical Stem Cell Fate Outcome Limits the Rate of Niche Succession in Human Colonic CryptsCraig Stamp, Anze Zupanic, Ashwin Sachdeva, et al.
European Urology Oncology|September 25, 2020
Can the Use of Serial Multiparametric Magnetic Resonance Imaging During Active Surveillance of Prostate Cancer Avoid the Need for Prostate Biopsies?-A Systematic Diagnostic Test Accuracy ReviewDinul Hettiarachchi, Rob Geraghty, Patrick Rice, et al.
NPJ Parkinson'S Disease|May 13, 2021
Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson's diseaseChun Chen, David McDonald, Alasdair Blain, et al.
Function (Oxford, England)|January 19, 2023
Integration of High-Throughput Imaging and Multiparametric Metabolic Profiling Reveals a Mitochondrial Mechanism of Tenofovir ToxicityAdam Pearson, Dominik Haenni, Jamal Bouitbir, et al.
Blood|February 9, 2023
Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphomaBenjamin J Stewart, Martin Fergie, Matthew D Young, et al.
JCO Oncology Practice|November 7, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone TherapyNeha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, et al.
BJU International|July 2, 2026
Venous thromboembolism after penile cancer surgery: a UK PeCaN studyAishwarya Kaur, Omar El-Taji, Hussain Alnajjar, et al.
The Journal of Clinical Investigation|March 31, 2026
Proliferation associates with greater sensitivity to androgen receptor pathway inhibition for metastatic prostate cancerLarissa Mendes, Peter F Dutey-Magni, Emily Grist, et al.
European Urology Oncology|November 5, 2024
Management of Small Testicular Masses: A Delphi Consensus StudyKarl H Pang, Giuseppe Fallara, João Lobo, et al.
The Lancet. Oncology|April 30, 2026
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trialsMahaz Kayani, Laura Murphy, Peter Dutey-Magni, et al.
Pageof 6